title: No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group.
authors.affiliation: German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany. Electronic address: karolin.behringer@uk-koeln.de.
authors.forename: K
authors.initials: K
authors.lastname: Behringer
authors.affiliation: University Hospital for Gynecology and Reproduction Medicine.
authors.forename: L
authors.initials: L
authors.lastname: Wildt
authors.affiliation: German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany.
authors.forename: H
authors.initials: H
authors.lastname: Mueller
authors.affiliation: University Hospital for Gynecology and Reproduction Medicine.
authors.forename: V
authors.initials: V
authors.lastname: Mattle
authors.affiliation: German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany.
authors.forename: P
authors.initials: P
authors.lastname: Ganitis
authors.affiliation: German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany.
authors.forename: B
authors.initials: B
authors.lastname: van den Hoonaard
authors.affiliation: Institute of Medical and Chemical Laboratory Diagnostics (ZIMCL), University Hospital Innsbruck, Innsbruck, Austria.
authors.forename: H W
authors.initials: HW
authors.lastname: Ott
authors.affiliation: Institute of Medical and Chemical Laboratory Diagnostics (ZIMCL), University Hospital Innsbruck, Innsbruck, Austria.
authors.forename: S
authors.initials: S
authors.lastname: Hofer
authors.affiliation: German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Pluetschow
authors.affiliation: German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany.
authors.forename: V
authors.initials: V
authors.lastname: Diehl
authors.affiliation: German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Engert
authors.affiliation: German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany.
authors.forename: P
authors.initials: P
authors.lastname: Borchmann
mesh_terms: D000293:Adolescent; D000328:Adult; D054304:Anti-Mullerian Hormone / Q000378:metabolism; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000627:therapeutic use; D015331:Cohort Studies; D003276:Contraceptives, Oral / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005047:Etoposide / Q000627:therapeutic use; D005260:Female; D005298:Fertility / Q000187:drug effects*; D005858:Germany; D007987:Gonadotropin-Releasing Hormone / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D009367:Neoplasm Staging; D006080:Ovarian Follicle / Q000187:drug effects*; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D015996:Survival Rate; D016896:Treatment Outcome; D014750:Vincristine / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D003276:Contraceptives, Oral; D001761:Bleomycin; D007987:Gonadotropin-Releasing Hormone; D011344:Procarbazine; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D054304:Anti-Mullerian Hormone; D003520:Cyclophosphamide; D011241:Prednisone